Turkish authorities reportedly detained more than 200 people, including suspected ISIS-linked militants, in a sweeping Tuesday raid in capital Ankara ahead of a July 7-8 NATO summit.

The raid came after Turkish authorities issued detention orders for 241 suspects, 209 of whom were taken into custody, The Associated Press reported, citing a statement from the office of Turkey’s chief prosecutor.

Among the 209 detained, 56 were allegedly ISIS militants, according to the AP. This comes after Turkish authorities said they detained 125 ISIS members in December.

The detention operations occurred just two weeks before a planned NATO summit in Ankara on July 7 that President Donald Trump is expected to attend.

TURKEY’S NATO ROLE UNDER SCRUTINY AMID NEW REPORT ON HAMAS, MUSLIM BROTHERHOOD TIES

Other militants scooped up were 35 alleged members of the Revolutionary People’s Liberation Party/Front, which a Turkish statement described as «a far‑left group known for armed attacks and assassinations in Turkey,» according to the AP.

The ISIS-combating operations demonstrate the terrorist group’s ongoing activity in the region, showing the group is still functioning despite the U.S. campaign during Trump’s first term to eliminate the group’s caliphate and its control of large swaths of territory in the Middle East.

Iraqi government forces celebrate while holding an Islamis Sate (IS) group flag after they claimed they have gained complete control of the Diyala province, northeast of Baghdad, on January 26, 2015 near the town of Muqdadiyah. (YOUNIS AL-BAYATI/AFP via Getty Images)

In recent years, ISIS has spread into the African continent, prompting a strong response from the U.S. In May, Trump authorized a series of strikes in Nigeria to combat the group.

PENTAGON SLASHES NATO COMBAT COMMITMENTS AS TRUMP PUSHES EUROPE TO DEFEND ITSELF

A May 16 strike killed ISIS leader Abu-Bilal al-Minuki, who was the group’s second-in-command globally.

U.S. and Nigerian forces conducted kinetic strikes against ISIS fighters in northeastern Nigeria on May 17, 2026, AFRICOM said. (X/U.S. Africa Command)

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

«Abu-Bilal al-Minuki, second in command of ISIS globally, thought he could hide in Africa, but little did he know we had sources who kept us informed on what he was doing,» Trump wrote in a post on Truth Social after the strike. «He will no longer terrorize the people of Africa, or help plan operations to target Americans.»

The group’s renewed activity also includes a call to supporters to make attacks on U.S. soil during the World Cup.

The Associated Press contributed to this report.

Más de 11.000 botellas de un medicamento utilizado para el tratamiento de la hipertensión arterial fueron retiradas del mercado de Estados Unidos después de detectarse que no cumplían con los parámetros de disolución exigidos por la autoridad sanitaria. La Administración de Alimentos y Medicamentos de Estados Unidos (FDA) informó que la medida afecta a pacientes que utilizan chlorthalidona de 25 miligramos. El retiro fue iniciado el 5 de junio de 2026 por el fabricante indio Inventia Healthcare Limited y abarca todo el territorio estadounidense a través de la distribuidora Rising Pharma Holdings, con sede en Nueva Jersey.

Según confirmaron tanto el informe oficial de la FDA como el reporte de Health.com, el retiro incluye exactamente 11.460 botellas en presentaciones de 100 y 1.000 tabletas, con fecha de vencimiento en abril de 2027 y los lotes identificados como RISA24001 y RISB24002. La agencia clasificó la medida como retiro Clase II, lo que significa que el uso del producto puede generar consecuencias adversas temporales o médicamente reversibles, aunque la probabilidad de efectos graves es baja. Por el momento, la FDA no ha reportado incidentes asociados ni ha emitido un comunicado de prensa específico sobre el caso.

La chlorthalidona es un diurético de uso extendido, recetado principalmente para el control de la presión arterial elevada y la retención de líquidos vinculada a enfermedades cardíacas, renales o hepáticas. El retiro se da en un contexto de vigilancia permanente sobre la calidad de los medicamentos, en un mercado donde los estándares regulatorios y la seguridad de los pacientes son una prioridad para las autoridades federales.

La FDA ordenó el retiro de la chlorthalidona 25 mg en 2026 debido a que las tabletas no cumplían con las especificaciones de disolución requeridas para su comercialización. Según el reporte oficial, “el incumplimiento de las especificaciones de disolución” significa que el comprimido puede no liberar el principio activo de manera adecuada en el organismo, lo que podría afectar la eficacia terapéutica del medicamento.

El retiro fue iniciado voluntariamente por Inventia Healthcare Limited luego de detectar en pruebas de laboratorio que los lotes afectados no superaban los controles de calidad exigidos. Good Housekeeping reportó que la disolución inadecuada puede traducirse en una absorción subóptima del fármaco, con el riesgo de que el paciente no reciba la dosis necesaria para controlar su condición. El informe de enforcement de la FDA puntualizó que la medida es de alcance nacional y afecta a todo el mercado estadounidense.

De acuerdo con el resumen publicado por la FDA, el retiro abarca dos lotes específicos del medicamento:

• RISA24001: botellas de 100 tabletas, NDC 64980-599-01.
• RISB24002: botellas de 1.000 tabletas, NDC 64980-599-10.

Ambas presentaciones tienen fecha de vencimiento en abril de 2027. El producto fue fabricado por Inventia Healthcare Limited en la India y distribuido en Estados Unidos por Rising Pharma Holdings. El total de unidades afectadas asciende a 11.460 botellas, según la información oficial de la agencia regulatoria.

El retiro se limita exclusivamente a los lotes y presentaciones mencionados. Otras dosis, marcas o presentaciones de chlorthalidona no están sujetas a la medida y permanecen disponibles en el mercado, según precisa la FDA en su sección de Enforcement Reports.

La chlorthalidona es un medicamento de la familia de los diuréticos tiazídicos, empleado en el tratamiento de la hipertensión arterial y en casos de retención de líquidos asociada a insuficiencia cardíaca, renal o hepática. Según el portal de la Cleveland Clinic, la chlorthalidona favorece la eliminación de sodio y agua a través de la orina, ayudando a reducir el volumen sanguíneo y, en consecuencia, la presión arterial.

El uso de este medicamento es frecuente en terapias combinadas para controlar la hipertensión y prevenir complicaciones cardiovasculares. De acuerdo con la FDA, la seguridad y eficacia de la chlorthalidona dependen de que el principio activo se libere y absorba correctamente en el organismo, objetivo que no se garantiza cuando el producto no cumple con las especificaciones de disolución.

La FDA recomienda a los pacientes que posean botellas de los lotes afectados no modificar ni suspender su tratamiento por cuenta propia. La agencia aconseja consultar con su médico o farmacéutico para evaluar posibles alternativas y coordinar el reemplazo del medicamento, si corresponde. El retiro fue notificado a los distribuidores y profesionales sanitarios mediante una carta formal, según consta en el informe oficial.

Health.com cita a la FDA: “Los consumidores deben seguir las indicaciones de su proveedor de atención médica para garantizar la continuidad y seguridad del tratamiento”. Además, la agencia subraya que la interrupción abrupta de medicamentos antihipertensivos puede suponer un riesgo para la salud, por lo que cualquier cambio debe realizarse bajo supervisión profesional.

El retiro fue clasificado por la FDA como Clase II, lo que implica que el uso del producto puede causar efectos adversos temporales o médicamente reversibles, con baja probabilidad de consecuencias graves. Esta categoría se emplea cuando el defecto del producto no representa un riesgo inminente de daño severo, pero sí justifica su retiro del mercado para prevenir complicaciones.

El reporte oficial señala que hasta ahora no se han registrado incidentes clínicos relacionados con el consumo de los lotes retirados, pero la agencia mantiene la medida como preventiva y continuará con el monitoreo. Las acciones de este tipo forman parte de los mecanismos regulares de control de calidad en la industria farmacéutica, establecidos por la legislación federal de Estados Unidos.

La FDA lleva a cabo auditorías periódicas, análisis de laboratorio y revisiones de cumplimiento para garantizar la seguridad y eficacia de los medicamentos distribuidos en el país. Los fabricantes están obligados a notificar cualquier desviación de los estándares y a retirar del mercado lotes que no cumplan con los parámetros exigidos. El retiro voluntario es una práctica habitual en la industria cuando los controles internos detectan fallas de calidad.

La disolución es uno de los parámetros clave en el control de calidad de los comprimidos. Según explica la FDA, el objetivo es asegurar que el principio activo se libere de manera predecible y sea absorbido por el organismo en la cantidad adecuada. Un defecto en este proceso puede comprometer el efecto terapéutico y la seguridad del paciente.

Los distribuidores y farmacias que tengan en inventario botellas de los lotes afectados deben aislarlas y suspender su comercialización de inmediato, según las instrucciones de la FDA. La agencia solicita que se notifique a los clientes y se gestione el reemplazo del producto conforme a las directrices oficiales.

El reporte de enforcement publicado en la web de la FDA detalla los números de lote y fecha de vencimiento a verificar. Los establecimientos pueden consultar la base de datos oficial para confirmar si poseen unidades sujetas al retiro y proceder conforme a los protocolos regulatorios.

El retiro representa una precaución para evitar el uso de medicamentos que puedan no cumplir con su función terapéutica. La decisión de la FDA pone de relieve la importancia de los controles de calidad y la vigilancia constante sobre los productos farmacéuticos. Los pacientes con medicamentos afectados deberán contar con el acompañamiento de sus profesionales de salud para continuar su tratamiento sin interrupciones.

El sistema de farmacovigilancia de Estados Unidos se mantiene activo y la FDA actualizará la información si surgen nuevos datos o si el alcance del retiro se amplía. Los usuarios pueden consultar la sección de Enforcement Reports en la página de la agencia para obtener información actualizada sobre este y otros retiros en curso.

La FDA publica actualizaciones periódicas sobre retiros de medicamentos en su sección de Enforcement Reports, accesible en En esa página, los usuarios pueden buscar por nombre del fármaco, número de lote o empresa fabricante para verificar si un producto está sujeto a retiro. La agencia recomienda a pacientes, profesionales sanitarios y distribuidores consultar esta fuente para confirmar la vigencia de los retiros y las acciones recomendadas.

EXCLUSIVE: As federal agents raced to dismantle an alleged plot targeting President Donald Trump’s UFC Freedom 250 event, investigators were simultaneously making another critical determination: whether the White House event itself could safely go forward.

In a Monday interview with Fox News Digital, FBI Deputy Director Chris Raia said investigators believed they had sufficiently disrupted the alleged conspiracy before the event took place, arguing that agents were monitoring suspects and knew none were in the Washington area when the UFC event was held.

«We absolutely felt very comfortable moving (the UFC event) forward,» Raia said. «We were confident that we had disrupted that main plot.»

The FBI initially arrested five people accused of participating in the plot to kill lawmakers and attendees at the June 14 event. Since then, prosecutors have publicly identified two additional defendants, raising questions about why the event was allowed to proceed while investigators continued pursuing other alleged participants.

5 CHILLING DETAILS FROM THE ALLEGED WHITE HOUSE ATTACK PLOT TIED TO UFC EVENT

Raia said the additional defendants were «followers» rather than leaders of the conspiracy.

«We were confident that we had the leaders, the main plotters of that, so the rest of the folks were more of the followers that you’re seeing now.»

«There was a lot of security there,» Vice President JD Vance said during a June 16 appearance on Fox News’ «The Five.» «And it turns out the plot was like, not that advanced. They weren’t in town.» 

The issue reportedly sparked tensions between federal agencies. 

Two senior U.S. officials previously told Fox News that Secret Service leadership wanted to delay publicly disclosing the investigation until additional arrests could be made, fearing that revealing the probe could alert other subjects and complicate the ongoing case.

Raia said the FBI did not share those concerns, arguing that investigators were already monitoring both the alleged ringleaders and other suspected participants.

FBI NAMES SIXTH SUSPECT IN ALLEGED PLOT TO USE DRONES AND SNIPERS TO TARGET UFC FREEDOM 250 EVENT

«We had that contained or what I would call mitigated very early on even though we didn’t do the arrests,» he said. «We were watching the folks that were planning it. We had them under surveillance. And so we knew that nobody was even close to the DC area at the time that was happening.» 

Despite reported disagreements over when to publicly disclose the investigation, Raia emphasized that the FBI and Secret Service worked closely throughout the case.

«That was a joint case with us and the Secret Service,» Raia said.

The agencies jointly assessed the threat before deciding the event could proceed, according to Raia.  

«We all talked about that as a group and made that decision to move forward with the UFC 250 event,» he told Fox News Digital.

Deputy Secret Service Director Matthew Quinn, responding to questions about the case at an unrelated event, emphasized that the Secret Service had «led that investigation from the beginning» and suggested investigators intentionally avoided public disclosure while the case remained active. 

«In order to maintain the integrity of the investigation and the security plan we chose not to leak it,» Quinn said during a June 16 press conference. 

Raia, a career FBI agent and former head of the bureau’s New York Field Office, was appointed FBI co-deputy director in January after the departure of former Deputy Director Dan Bongino. Before leading the New York office, Raia served as one of the FBI’s top counterterrorism officials and has been with the bureau since 2003.

President Donald Trump seated between Dana White and the First Lady. (Evan Vucci/Reuters)

According to court records, the alleged conspirators first connected through a TikTok community known as «Vanguard of the Old» before moving their discussions to encrypted messaging platforms including Signal, Telegram and SimpleX. Investigators say members organized themselves into tiered roles that included frontline operators, drone operators, recruiters, logistics personnel and technical support.

Court records indicate the network extended well beyond the suspects initially charged. After obtaining a warrant for the phone of Ohio defendant Tycen Proper, investigators allegedly discovered a primary Signal chat containing approximately 19 participants, along with smaller operational chats organized by role and location.

Raia said the case is far from closed: 14 to 15 FBI field offices are assisting in the investigation.

«We’re going to continue to work that case aggressively,» he said. «You uncover one layer, and you see four more layers.»

The case also underscored one of the FBI’s biggest investigative challenges: encrypted communications platforms.

«That is a gap for us in encrypted communications platforms,» Raia said.

UFC Freedom 250 takes place on the South Lawn of the White House in Washington on Mon. June 15, 2026. (Jacquelyn Martin/AP)

Raia said investigators attempt to penetrate those networks through confidential human sources, undercover employees and other lawful investigative techniques. 

«We try to infiltrate, obviously, with CHSs, UCEs, again, inside the bounds of the Constitution,» he said, referring to «confidential human sources» and «undercover employees.» 

But Raia acknowledged the FBI does not have visibility into every encrypted chat where criminal activity may be occurring. 

In the UFC case, he pointed to Proper’s mother as the catalyst who helped investigators uncover the alleged conspiracy before it could advance further.

«We had a concerned parent that really launched this entire UFC 250 case off,» Raia said. «Concerned parent called in on her son.»

The tip ultimately led investigators to Proper’s phone and the alleged network of encrypted chats that prosecutors say contained discussions about drones, sniper positions, escape routes and attack planning. Without that initial call, Raia suggested, the alleged plot may have remained hidden inside encrypted platforms that continue to challenge law enforcement visibility.

The UFC case also reflects what FBI officials say is a broader shift in the threat landscape. Rather than large, hierarchical terrorist organizations, investigators are increasingly concerned about lone actors and small groups that can organize online, acquire commercially available technology and develop attack plans with little outside support.

«I’m less concerned about a mass 9/11 style attack than I am a lone single person, a single attacker,» he said.

While discussing security preparations for the FIFA World Cup, he described drone-based attacks as one of the FBI’s top concerns and warned that tactics seen on battlefields overseas could eventually migrate to the United States.

Investigators say they saw signs that the alleged network may have been considering targets beyond the White House UFC event. 

In a newly unsealed court filing, an FBI agent said he believed messages exchanged among alleged conspirators referenced a potential attack on a FIFA World Cup match scheduled for July 3 in Kansas City, Missouri.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

«I think that is a threat that is emerging,» Raia said. «We have seen that overseas, and it’s only a matter of time for somebody brings that type of attack, that threat vector here to the United States.»

The alleged UFC plot illustrates many of those concerns. Prosecutors say the group allegedly used encrypted communications, divided members into specialized roles, discussed drone operations and coordinated activity across multiple states without relying on a traditional terrorist organization or foreign network.

This story is part of Fox News Digital’s exclusive interview with FBI Deputy Director Chris Raia. Additional reporting from the interview will be published in the coming days.

Fox News’ Mike Ruiz contributed to this report.